Kymera Therapeutics
Dapeng Chen has extensive experience in drug metabolism and pharmacokinetics (DMPK), serving as Senior Director DMPK at Kymera Therapeutics and previously as Director and Associate Director DMPK in the same organization. Prior to that role, Dapeng held the position of Associate Director DMPK at KSQ Therapeutics, Inc. and worked as an Associate Principal Scientist at Merck Research Laboratories Boston. This cumulative experience highlights a strong background in the field of DMPK.
This person is not in any teams
Kymera Therapeutics
5 followers
Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.